Abstract. Microarray technology has provided biologists with the ability to measure the expression levels of thousands of genes in a single experiment. One of the urgent issues in the use of microarray data is the selection of a small subset of genes from the thousands of genes in the data that contributes to a disease. This selection process is difficult due to many irrelevant genes, noisy genes, and the availability of the small number of samples compared to the huge number of genes (high-dimensional data
1. Introduction. The recent development of microarray technologies has enabled biologists to quantify the expression levels of thousands of genes in a single experiment. It finally produces microarray data. A comparison between the gene expression levels of cancerous and normal tissues can also be done. This comparison is useful to select those genes that might anticipate the clinical behaviour of cancers. Thus, there is a need to select informative genes that contribute to a cancerous state. An informative gene is useful for cancer classification. However, the gene selection process poses a major challenge because of the following characteristics of microarray data: the huge number of genes compared to the small number of samples (high-dimensional data), irrelevant genes and noisy data.
To overcome the challenge, a gene selection method is normally used to select a subset of genes that increases the classifier's ability to classify samples more accurately. Efficient
